Memantine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Northstar Rxllc. The primary component is Memantine Hydrochloride.
| Product ID | 72603-118_d7b3a7ae-9fad-87a9-cffc-0304b83848bb |
| NDC | 72603-118 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Memantine |
| Generic Name | Memantine |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-09-13 |
| Marketing Category | ANDA / |
| Application Number | ANDA090048 |
| Labeler Name | NorthStar RxLLC |
| Substance Name | MEMANTINE HYDROCHLORIDE |
| Active Ingredient Strength | 5 mg/1 |
| Pharm Classes | N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-09-13 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0615-8100 | Memantine | Memantine |
| 0615-8192 | Memantine | Memantine |
| 0615-8319 | Memantine | Memantine |
| 0904-6505 | Memantine | Memantine |
| 0904-6506 | Memantine | Memantine |
| 55111-596 | Memantine | Memantine |
| 55111-597 | Memantine | Memantine |
| 55154-4151 | Memantine | Memantine |
| 55154-7637 | Memantine | Memantine |
| 60505-6162 | MEMANTINE | memantine hydrochloride |
| 60687-173 | Memantine | Memantine |
| 60687-184 | Memantine | Memantine |
| 0378-1103 | Memantine Hydrochloride | memantine |
| 0378-1104 | Memantine Hydrochloride | memantine |
| 0378-5435 | Memantine Hydrochloride | memantine |
| 0378-5436 | Memantine Hydrochloride | memantine |
| 0378-5437 | Memantine Hydrochloride | memantine |
| 0378-5438 | Memantine Hydrochloride | memantine |
| 42291-551 | Memantine hydrochloride | Memantine |
| 42291-552 | Memantine hydrochloride | Memantine |
| 42292-005 | Memantine Hydrochloride | memantine |
| 42292-006 | Memantine Hydrochloride | memantine |
| 53746-169 | Memantine hydrochloride | Memantine |
| 53746-173 | Memantine hydrochloride | Memantine |